Erasca, Inc. (ERAS)
3.23
-0.07
(-2.12%)
USD |
NASDAQ |
Dec 10, 15:29
Erasca Market Cap: 916.39M for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ALX Oncology Holdings, Inc. | 82.41M |
| Prelude Therapeutics, Inc. | 106.24M |
| Atea Pharmaceuticals, Inc. | 248.44M |
| Immuneering Corp. | 396.46M |
| ProKidney Corp. | 307.15M |
Market Cap Related Metrics
| Price to Book Value | 2.634 |
| Price | 3.23 |
| Earnings Yield | -13.96% |